SKI Market

A+| A| A-|

Indian Indices

Sensex

77,763.91 0.00
( 0.00%)

Global Indices

Nasdaq

52,921.07 594.83
(1.14%)

Dow Jones

7,504.24 0.01
(0.00%)

Hang Seng

69,733.68 1,000.53
(1.46%)

Nikkei 225

10,673.34 20.47
(0.19%)

Forex

USD-INR

95.28 0.28
(0.30%)

EUR-INR

108.75 0.54
(0.50%)

GBP-INR

126.99 1.06
(0.84%)

JPY-INR

0.59 0.01
(0.97%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bacil Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524516

INE711D01018

17.5524281

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

36.9

57.2

EPS(TTM)

Face Value()

Div & Yield %

1.08

Back

GTL reports standalone net loss of Rs 2.63 crore in the December 2025 quarter

Feb 12,2026

Net Loss of GTL reported to Rs 2.63 crore in the quarter ended December 2025 as against net loss of Rs 41.82 crore during the previous quarter ended December 2024. Sales rose 7.78% to Rs 55.00 crore in the quarter ended December 2025 as against Rs 51.03 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	55.00	51.03	8
OPM %	14.95	-50.62	-
PBDT	-0.74	-34.36	98
PBT	-2.63	-37.32	93
NP	-2.63	-41.82	94

77,763.91 0.00 ( 0.00%)

52,921.07 594.83 (1.14%)

7,504.24 0.01 (0.00%)

69,733.68 1,000.53 (1.46%)

10,673.34 20.47 (0.19%)

95.28 0.28 (0.30%)

108.75 0.54 (0.50%)

126.99 1.06 (0.84%)

0.59 0.01 (0.97%)